These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Somatic and germline genomics in paediatric acute lymphoblastic leukaemia. Pui CH; Nichols KE; Yang JJ Nat Rev Clin Oncol; 2019 Apr; 16(4):227-240. PubMed ID: 30546053 [TBL] [Abstract][Full Text] [Related]
6. Towards an understanding of the biology and targeted treatment of paediatric relapsed acute lymphoblastic leukaemia. Irving JA Br J Haematol; 2016 Mar; 172(5):655-66. PubMed ID: 26568036 [TBL] [Abstract][Full Text] [Related]
7. Insights of Acute Lymphoblastic Leukemia with Development of Genomic Investigation. Xu H; Shu Y Methods Mol Biol; 2018; 1754():387-413. PubMed ID: 29536454 [TBL] [Abstract][Full Text] [Related]
8. Molecular-based and antibody-based targeted pharmacological approaches in childhood acute lymphoblastic leukemia. Tardif M; Souza A; Krajinovic M; Bittencourt H; Tran TH Expert Opin Pharmacother; 2021 Oct; 22(14):1871-1887. PubMed ID: 34011251 [No Abstract] [Full Text] [Related]
9. The biology of relapsed acute lymphoblastic leukemia: opportunities for therapeutic interventions. Bhatla T; Jones CL; Meyer JA; Vitanza NA; Raetz EA; Carroll WL J Pediatr Hematol Oncol; 2014 Aug; 36(6):413-8. PubMed ID: 24942023 [TBL] [Abstract][Full Text] [Related]
10. Application of genomics for risk stratification of childhood acute lymphoblastic leukaemia: from bench to bedside? Izraeli S Br J Haematol; 2010 Oct; 151(2):119-31. PubMed ID: 20678159 [TBL] [Abstract][Full Text] [Related]
11. Driving Toward Precision Medicine for Acute Leukemias: Are We There Yet? Chung C; Ma H Pharmacotherapy; 2017 Sep; 37(9):1052-1072. PubMed ID: 28654205 [TBL] [Abstract][Full Text] [Related]
12. Advances in therapy for Philadelphia-positive acute lymphoblastic leukaemia of childhood and adolescence. Bleckmann K; Schrappe M Br J Haematol; 2016 Mar; 172(6):855-69. PubMed ID: 26773444 [TBL] [Abstract][Full Text] [Related]
13. Treatment and biology of pediatric acute lymphoblastic leukemia. Kato M; Manabe A Pediatr Int; 2018 Jan; 60(1):4-12. PubMed ID: 29143423 [TBL] [Abstract][Full Text] [Related]
15. New strategies in acute lymphoblastic leukemia: translating advances in genomics into clinical practice. Mullighan CG Clin Cancer Res; 2011 Feb; 17(3):396-400. PubMed ID: 21149616 [TBL] [Abstract][Full Text] [Related]
16. [Present status of individualized therapy in childhood acute lymphoblastic leukemia]. Wang J; Chen C Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1617-22. PubMed ID: 24370059 [TBL] [Abstract][Full Text] [Related]
17. Precision medicine approaches may be the future for CRLF2 rearranged Down Syndrome Acute Lymphoblastic Leukaemia patients. Page EC; Heatley SL; Yeung DT; Thomas PQ; White DL Cancer Lett; 2018 Sep; 432():69-74. PubMed ID: 29879498 [TBL] [Abstract][Full Text] [Related]
18. Current challenges and opportunities in treating adult patients with Philadelphia-negative acute lymphoblastic leukaemia. Wolach O; Amitai I; DeAngelo DJ Br J Haematol; 2017 Dec; 179(5):705-723. PubMed ID: 29076138 [TBL] [Abstract][Full Text] [Related]